GW Pharmaceuticals Announces The Closing Of Its U.S. Follow-On Offering Of American Depositary Shares (Adss) On The NASDAQ Global Market And Full Exercise Of Underwriters' Option To Purchase Additional AdSs
1/15/2014 8:08:50 AM
LONDON, Jan. 14, 2014 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) ("GW" or the "Company"), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced today the closing of its previously announced follow-on offering on the NASDAQ Global Market of 2,441,110 American Depositary Shares (ADSs) and the full exercise by the underwriters of their option to purchase 366,165 additional ADSs at a price of $36.00 per ADS raising gross proceeds of $101.1 million (before deducting underwriting discount, commissions and offering expenses).
Help employers find you! Check out all the jobs and post your resume.
comments powered by